MCI Onehealth Technologies Inc.

Symbol: DRDR.TO




Market price today

  • -1.4272

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 49.43M

    MRK Cap

  • 0.00%

    DIV Yield

MCI Onehealth Technologies Inc. (DRDR-TO) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Care Facilities
CEO:Dr. Alexander Julian Dobranowski
Full-time employees:340
Address:4881 Yonge Street

MCI Onehealth Technologies Inc., through its subsidiaries, provides healthcare and healthcare related services to patients and the employees of corporate customers in Canada. The company provides its services through a network of 25 brick and mortar clinics, as well as through telehealth/virtual care platform. The company was formerly known as MCI Brighthealth Technologies Inc. and changed its name to MCI Onehealth Technologies Inc. in December 2020. MCI Onehealth Technologies Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

General Outlook

When we look at how much money they make before expenses, they keep 0.312% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.385%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.528%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.494% return, is a testament to MCI Onehealth Technologies Inc.'s adeptness in optimizing resource deployment. MCI Onehealth Technologies Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.829%. Furthermore, the proficiency of MCI Onehealth Technologies Inc. in capital utilization is underscored by a remarkable -0.737% return on capital employed.

Liquidity Ratios

Analyzing DRDR.TO liquidity ratios reveals its financial health of the firm. The current ratio of 34.28% gauges short-term asset coverage for liabilities. The quick ratio (30.74%) assesses immediate liquidity, while the cash ratio (6.77%) indicates cash reserves.

Current Ratio34.28%
Quick Ratio30.74%
Cash Ratio6.77%

Profitability Ratios

DRDR.TO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -44.63% underscores its earnings before tax deductions. The effective tax rate stands at -18.00%, revealing its tax efficiency. The net income per EBT, 118.24%, and the EBT per EBIT, 115.90%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -38.51%, we grasp its operational profitability.

Pretax Profit Margin-44.63%
Effective Tax Rate-18.00%
Net Income per EBT118.24%
EBT per EBIT115.90%
EBIT per Revenue-38.51%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.34, it details the span from stock purchase to revenue.

Days of Sales Outstanding31
Operating Cycle43.65
Days of Payables Outstanding125
Cash Conversion Cycle-82
Receivables Turnover8.36
Payables Turnover2.91
Fixed Asset Turnover3.84
Asset Turnover0.94

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.09, and free cash flow per share, -0.09, depict cash generation on a per-share basis. The cash per share value, 0.04, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.12, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.09
Free Cash Flow per Share-0.09
Cash per Share0.04
Operating Cash Flow Sales Ratio-0.12
Free Cash Flow to Operating Cash Flow Ratio1.08
Cash Flow Coverage Ratio-0.24
Short Term Coverage Ratio-0.40
Capital Expenditure Coverage Ratio-12.84
Dividend Paid and Capex Coverage Ratio-12.84

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 46.13%, highlights its total liabilities relative to assets. With a debt-equity ratio of 2.55, we discern the balance between debt and equity financing. The long-term debt to capitalization, 50.87%, and total debt to capitalization, 71.81%, ratios shed light on its capital structure. An interest coverage of -24.46 indicates its ability to manage interest expenses.

Debt Ratio46.13%
Debt Equity Ratio2.55
Long Term Debt to Capitalization50.87%
Total Debt to Capitalization71.81%
Interest Coverage-24.46
Cash Flow to Debt Ratio-0.24
Company Equity Multiplier5.52

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.06, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.42, reflects the portion of profit attributed to each share. The book value per share, 0.24, represents the net asset value distributed per share, while the tangible book value per share, -0.16, excludes intangible assets.

Revenue Per Share1.06
Net Income Per Share-0.42
Book Value Per Share0.24
Tangible Book Value Per Share-0.16
Shareholders Equity Per Share0.24
Interest Debt Per Share0.36
Capex Per Share-0.02

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.30%, indicates top-line expansion, while the gross profit growth, 10.72%, reveals profitability trends. EBIT growth, -23.86%, and operating income growth, -23.86%, offer insights into operational profitability progression. The net income growth, -34.56%, showcases bottom-line expansion, and the EPS growth, -27.27%, measures the growth in earnings per share.

Revenue Growth11.30%
Gross Profit Growth10.72%
EBIT Growth-23.86%
Operating Income Growth-23.86%
Net Income Growth-34.56%
EPS Growth-27.27%
EPS Diluted Growth-27.27%
Weighted Average Shares Growth4.33%
Weighted Average Shares Diluted Growth4.33%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth-17.58%
Free Cash Flow Growth-0.51%
10-Year Revenue Growth per Share100.20%
5-Year Revenue Growth per Share100.20%
3-Year Revenue Growth per Share88.27%
10-Year Operating CF Growth per Share-489.48%
5-Year Operating CF Growth per Share-489.48%
3-Year Operating CF Growth per Share-525.33%
10-Year Net Income Growth per Share-1213946.04%
5-Year Net Income Growth per Share-1213946.04%
3-Year Net Income Growth per Share-28607.34%
3-Year Shareholders Equity Growth per Share800.53%
Receivables Growth-11.08%
Asset Growth-25.06%
Book Value per Share Growth-61.73%
Debt Growth21.42%
R&D Expense Growth5154.19%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 46,054,121.2, captures the company's total value, considering both debt and equity. Income quality, 0.40, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.50, gauges operational efficiency, while the research and development to revenue, 15.30%, highlights investment in innovation. The ratio of intangibles to total assets, 46.73%, indicates the value of non-physical assets, and capex to operating cash flow, 13.99%, measures reinvestment capability.

Enterprise Value46,054,121.2
Income Quality0.40
Sales General and Administrative to Revenue0.50
Research and Development to Revenue15.30%
Intangibles to Total Assets46.73%
Capex to Operating Cash Flow13.99%
Capex to Revenue-2.19%
Capex to Depreciation-22.15%
Stock-Based Compensation to Revenue9.08%
Graham Number1.49
Return on Tangible Assets-86.74%
Graham Net Net-0.52
Working Capital-10,783,000
Tangible Asset Value-7,827,000
Net Current Asset Value-23,530,000
Invested Capital1
Average Receivables5,977,500
Average Payables6,241,500
Days Sales Outstanding39
Days Payables Outstanding57

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.89, and the price to book ratio, 3.89, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.30, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -10.35, and price to operating cash flows, -6.45, gauge market valuation against cash flow metrics.

Price Book Value Ratio3.89
Price to Book Ratio3.89
Price to Sales Ratio1.30
Price Cash Flow Ratio-6.45
Enterprise Value Multiple-3.05
Price Fair Value3.89
Price to Operating Cash Flow Ratio-6.45
Price to Free Cash Flows Ratio-10.35
Price to Tangible Book Ratio2.55
Enterprise Value to Sales0.87
Enterprise Value Over EBITDA-3.05
EV to Operating Cash Flow-5.52
Earnings Yield-70.18%
Free Cash Flow Yield-31.67%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of MCI Onehealth Technologies Inc. (DRDR.TO) on the TSX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -1.427 in 2024.

What is the ticker symbol of MCI Onehealth Technologies Inc. stock?

The ticker symbol of MCI Onehealth Technologies Inc. stock is DRDR.TO.

What is company IPO date?

IPO date of MCI Onehealth Technologies Inc. is 2021-01-06.

What is company current share price?

Current share price is 0.550 CAD.

What is stock market cap today?

The market cap of stock today is 49428392.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 340.